Cargando…
Efficacy of remdesivir for hospitalized COVID-19 patients with end stage renal disease
BACKGROUND: Since the beginning of corona virus disease 2019 (COVID-19) pandemic, there has been a widespread use of remdesivir in adults and children. There is little known information about its outcomes in patients with end stage renal disease who are on dialysis. AIM: To assess the clinical outco...
Autores principales: | Selvaraj, Vijairam, Lal, Amos, Finn, Arkadiy, Tanzer, Joshua Ray, Baig, Muhammad, Jindal, Atin, Dapaah-Afriyie, Kwame, Bayliss, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788204/ https://www.ncbi.nlm.nih.gov/pubmed/35433306 http://dx.doi.org/10.5492/wjccm.v11.i1.48 |
Ejemplares similares
-
Association of Treatment with Remdesivir and 30-day Hospital Readmissions in Patients Hospitalized with COVID-19
por: Finn, Arkadiy, et al.
Publicado: (2022) -
Severe multisystem inflammatory syndrome in a vaccinated adult with COVID-19
por: Selvaraj, Vijairam, et al.
Publicado: (2022) -
The Treatment of COVID-19 Purgatory Syndrome With Tocilizumab and Steroids
por: Selvaraj, Vijairam, et al.
Publicado: (2022) -
Baricitinib in hospitalised patients with COVID-19: A meta-analysis of randomised controlled trials
por: Selvaraj, Vijairam, et al.
Publicado: (2022) -
Complete heart block associated with Remdesivir in COVID-19: a case report
por: Selvaraj, Vijairam, et al.
Publicado: (2021)